TrialBlood2012

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

Javier Bolaños-Meade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.